+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bristol-Myers Squibb - logo

Bristol-Myers Squibb is a pharmaceutical company that develops products for various diseases, such as oncology, virology, cardiovascular diseases, serious mental illness, and immunoscience. The company has delivered 12 new medicines to patients in the past 7 years. It also provides products for Alzheimer's disease, atherosclerosis/thrombosis, hepatitis, HIV/AIDS, solid organ transplant rejection, and a wide variety of other diseases and disorders. Bristol-Myers Squibb was founded in 1990 and is based in Uxbridge, United Kingdom.

Biologics - Global Strategic Business Report - Product Thumbnail Image

Biologics - Global Strategic Business Report

  • Report
  • April 2025
  • 293 Pages
  • Global
From
Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033 - Product Thumbnail Image

Global Antibody Therapeutic Market: Focus on Format, Disease Area, Route of Administration, End Users, Region, and Competitive Landscape - Analysis and Forecast, 2024-2033

  • Report
  • December 2023
  • 137 Pages
  • Global
From
Industry Snapshots: US Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: US Pharmaceuticals

  • Newsletter
  • April 2025
  • 50 Pages
  • United States
From
Industry Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: UK Pharmaceuticals

  • Newsletter
  • April 2025
  • 50 Pages
  • United Kingdom
From
Biological Drugs - Global Strategic Business Report - Product Thumbnail Image

Biological Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
Peptide Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Peptide Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Oropharyngeal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 417 Pages
  • Global
From
Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Head and Neck Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 4115 Pages
  • Global
From
Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Gastric Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 1834 Pages
  • Global
From
Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Adrenocortical Carcinoma (Adrenal Cortex Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 74 Pages
  • Global
From
LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report - Product Thumbnail Image

LAG-3 Targeting Therapy Market, Drug Dosage, Patent, Sales & Clinical Trials Insight 2030 Report

  • Report
  • April 2025
  • 190 Pages
  • Global
From
Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034 - Product Thumbnail Image

Cutaneous T-Cell Lymphoma - Market Insight, Epidemiology and Market Forecast - 2034

  • Drug Pipelines
  • March 2024
  • 210 Pages
  • Global
From
Chronic lymphocytic leukemia - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic lymphocytic leukemia - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 210 Pages
  • Global
From
Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024 - Product Thumbnail Image

Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Refractory Multiple Myeloma - Pipeline Insight, 2024 - Product Thumbnail Image

Refractory Multiple Myeloma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Major Depressive Disorder Market Report 2025 - Product Thumbnail Image

Major Depressive Disorder Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Postpartum Depression Market Report 2025 - Product Thumbnail Image

Postpartum Depression Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034 - Product Thumbnail Image

Multiple Myeloma - Market Insight, Epidemiology, and Market Forecast - 2034

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Antidepressants Market Report 2025 - Product Thumbnail Image

Antidepressants Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Effervescent Tablet Market Report and Forecast 2024-2032 - Product Thumbnail Image

Effervescent Tablet Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 160 Pages
  • Global
From
Loading Indicator